High-dose stimulants for attention-deficit/hyperactivity disorder a review of the clinical effectiveness, safety and guidelines
This review considers the use of short, intermediate, and/or long acting stimulants, such as, methylphenidate, amphetamine, dextro-amphetamine, and lisdexamfetamine, in children and adults. Many persons with attention-deficit/hyperactivity disorder (ADHD) require individualized, optimal dose-titrati...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Ottawa]
Canadian Agency for Drugs and Technologies in Health
2016, 3 March 2016
|
| Series: | Rapid response report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This review considers the use of short, intermediate, and/or long acting stimulants, such as, methylphenidate, amphetamine, dextro-amphetamine, and lisdexamfetamine, in children and adults. Many persons with attention-deficit/hyperactivity disorder (ADHD) require individualized, optimal dose-titration to address symptoms, and it is recommended that patients start on the lowest possible dose and titrate upwards to appropriately manage symptoms. This review aims to address concerns regarding the effectiveness and safety of the use of stimulants at higher than recommended doses |
|---|---|
| Physical Description: | 1 PDF file (24 pages) |